CSHCN 2009 > Physician > Benefits, Limitations, and Authorization Requirements

29.2.26.6 Cytopathology Studies (Gynecological, Pap Smears)

Pap smears for early detection of cancer are a benefit of the CSHCN Services Program.

Procurement and handling of the Pap smears are considered part of the E/M of the client and will not be reimbursed separately. Physicians interpreting a cytopathology specimen (Pap smears) must report the place of service according to where the cytopathology specimen is interpreted (office, inpatient hospital, outpatient hospital, or independent lab).

Because of the technical nature of processing and interpreting Pap smears or specimen for cytopathology, pathologists are the only physician specialty reimbursed for these services.

Refer to: Section 23.2.8, "Cytopathology of Vaginal, Cervical, and Uterine Sites" for additional information concerning coding and reimbursement for gynecological cytopathology studies.